Published February 2017 | Version v1
Journal article

Application of 18F-NaF PET/CT in patients with bone metastasis from prostate cancer

  • 1. Department of Nuclear Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou (China)

Description

There has been a growing number of prostate cancer patients in our country, and most of the patients suffer with bone metastases. Although more and more new drugs are reported for the treatment of prostate cancer, tumor local recurrence or metastasis occur within the 10 years after treatment. The diagnostic sensitivity of 18F-NaF PET/CT for bone metastases from prostate cancer is high. 18F-NaF PET/CT not only can locate the lesion precisely, evaluate the drug efficacy quantitatively, but also can be used to follow up prostate cancer patients. This review is focused on the application of 18F-NaF PET/CT in bone metastases from prostate cancer. (authors)

Additional details

Publishing Information

Journal Title
Chinese Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
37
Journal Issue
2
Journal Page Range
p. 108-110
ISSN
2095-2848

Optional Information

Notes
31 refs.; http://dx.doi.org/10.3760/cma.j.issn.2095-2848.2017.02.013